Annual ROE:
-19.20%-11.03%(-135.01%)Summary
- As of today, CRSP annual return on equity is -19.20%, with the most recent change of -11.03% (-135.01%) on December 31, 2024.
- During the last 3 years, CRSP annual ROE has fallen by -37.79% (-203.28%).
- CRSP annual ROE is now -102.39% below its all-time high of 802.83%, reached on December 31, 2014.
Performance
CRSP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-24.90%-5.15%(-26.08%)Summary
- As of today, CRSP quarterly return on equity is -24.90%, with the most recent change of -5.15% (-26.08%) on June 30, 2025.
- Over the past year, CRSP quarterly ROE has dropped by -10.90% (-77.86%).
- CRSP quarterly ROE is now -192.88% below its all-time high of 26.81%, reached on June 30, 2021.
Performance
CRSP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CRSP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -135.0% | -77.9% |
| 3Y3 Years | -203.3% | +6.8% |
| 5Y5 Years | -291.2% | -1039.6% |
CRSP ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -203.3% | +36.9% | -196.8% | +19.1% |
| 5Y | 5-Year | -203.3% | +36.9% | -192.9% | +19.1% |
| All-Time | All-Time | -102.4% | +87.1% | -192.9% | +54.7% |
CRSP ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -24.90%(-26.1%) |
| Mar 2025 | - | -19.75%(-5.9%) |
| Dec 2024 | -19.20%(-135.0%) | -18.65%(-49.7%) |
| Sep 2024 | - | -12.46%(+11.0%) |
| Jun 2024 | - | -14.00%(-20.8%) |
| Mar 2024 | - | -11.59%(-38.1%) |
| Dec 2023 | -8.17%(+73.1%) | -8.39%(+56.2%) |
| Sep 2023 | - | -19.16%(+11.6%) |
| Jun 2023 | - | -21.68%(+17.1%) |
| Mar 2023 | - | -26.15%(+15.0%) |
| Dec 2022 | -30.42%(-263.6%) | -30.77%(-1.3%) |
| Sep 2022 | - | -30.39%(-13.7%) |
| Jun 2022 | - | -26.72%(-298.4%) |
| Mar 2022 | - | 13.47%(-21.6%) |
| Dec 2021 | 18.59%(+169.4%) | 17.19%(-17.1%) |
| Sep 2021 | - | 20.74%(-22.6%) |
| Jun 2021 | - | 26.81%(+190.3%) |
| Mar 2021 | - | -29.68%(+2.3%) |
| Dec 2020 | -26.80% | -30.37%(-34.3%) |
| Sep 2020 | - | -22.61%(-953.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | 2.65%(-63.1%) |
| Mar 2020 | - | 7.19%(-42.6%) |
| Dec 2019 | 10.04%(+117.6%) | 12.52%(+577.9%) |
| Sep 2019 | - | -2.62%(+95.2%) |
| Jun 2019 | - | -54.99%(-3.7%) |
| Mar 2019 | - | -53.04%(+0.2%) |
| Dec 2018 | -56.89%(-75.0%) | -53.12%(-21.4%) |
| Sep 2018 | - | -43.76%(-7.4%) |
| Jun 2018 | - | -40.73%(-15.9%) |
| Mar 2018 | - | -35.13%(-4.1%) |
| Dec 2017 | -32.50%(-87.9%) | -33.75%(-24.5%) |
| Sep 2017 | - | -27.11%(-18.4%) |
| Jun 2017 | - | -22.89%(-0.6%) |
| Mar 2017 | - | -22.75%(-42.5%) |
| Dec 2016 | -17.30%(+88.4%) | -15.97%(+57.8%) |
| Sep 2016 | - | -37.87%(+3.3%) |
| Jun 2016 | - | -39.15%(+1.7%) |
| Mar 2016 | - | -39.81%(-261.2%) |
| Dec 2015 | -148.89%(-118.5%) | 24.70% |
| Dec 2014 | 802.83% | - |
FAQ
- What is CRISPR Therapeutics AG annual return on equity?
- What is the all-time high annual ROE for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual ROE year-on-year change?
- What is CRISPR Therapeutics AG quarterly return on equity?
- What is the all-time high quarterly ROE for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly ROE year-on-year change?
What is CRISPR Therapeutics AG annual return on equity?
The current annual ROE of CRSP is -19.20%
What is the all-time high annual ROE for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual return on equity is 802.83%
What is CRISPR Therapeutics AG annual ROE year-on-year change?
Over the past year, CRSP annual return on equity has changed by -11.03% (-135.01%)
What is CRISPR Therapeutics AG quarterly return on equity?
The current quarterly ROE of CRSP is -24.90%
What is the all-time high quarterly ROE for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly return on equity is 26.81%
What is CRISPR Therapeutics AG quarterly ROE year-on-year change?
Over the past year, CRSP quarterly return on equity has changed by -10.90% (-77.86%)